Category: Life Sciences
Global Life Sciences
-
Implantable Medical Devices
... at a CAGR of 6.0% over the analysis period 2024-2030. Orthopedic Implants, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$62.6 Billion by the end of ... Read More
-
Infectious Disease Diagnostics
... at a CAGR of 5.5% over the analysis period 2024-2030. Diagnostic Assays & Reagents, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$25.8 Billion by the ... Read More
-
Intraoperative Imaging
... CAGR of 4.4% over the analysis period 2024-2030. Mobile C-Arms, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$1.8 Billion by the end of the analysis ... Read More
-
Intrathecal Pumps
... CAGR of 5.1% over the analysis period 2024-2030. Morphine, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$115.9 Million by the end of the analysis period. ... Read More
-
Knee Reconstruction Devices
... at a CAGR of 4.3% over the analysis period 2024-2030. Primary Knee Reconstruction Devices, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$8.1 Billion by the ... Read More
-
Medical Power Supply
... at a CAGR of 5.4% over the analysis period 2024-2030. AC-DC Power Supply, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$2.2 Billion by the end ... Read More
-
Mobile Health and Fitness Sensors
... Billion by 2030, growing at a CAGR of 12.1% over the analysis period 2024-2030. Healthcare End-Use, one of the segments analyzed in the report, is expected to record a 12.7% CAGR and reach US$6.0 Billion ... Read More
-
Multi-Parameter Patient Monitoring Equipment
... 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. Portable Device, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$12.8 Billion by the ... Read More
-
Multiplex Assays
... CAGR of 6.4% over the analysis period 2024-2030. Multiplex Assay Consumables, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$3.7 Billion by the end of the ... Read More
-
Nanosensors
... 58.6% over the analysis period 2024-2030. Healthcare End-Use, one of the segments analyzed in the report, is expected to record a 61.3% CAGR and reach US$14.1 Billion by the end of the analysis period. Growth ... Read More
-
Non-Vascular Stents
... CAGR of 5.1% over the analysis period 2024-2030. Urology Stents, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$1.1 Billion by the end of the analysis ... Read More
-
Nucleic Acid Labeling
... at a CAGR of 7.5% over the analysis period 2024-2030. Nucleic Acid Labeling Reagents, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$2.4 Billion by the ... Read More
-
Ocular Implants
... CAGR of 4.2% over the analysis period 2024-2030. Glaucoma Implants, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$6.5 Billion by the end of the analysis ... Read More
-
Oncology Molecular Diagnostics
... at a CAGR of 11.1% over the analysis period 2024-2030. Breast Cancer Indication, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$2.9 Billion by the end ... Read More
-
Optical Emission Spectroscopy (OES)
... 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. OES Equipment, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$718.1 Million by the ... Read More
-
Organic Essential Oils
... at a CAGR of 9.0% over the analysis period 2024-2030. Supermarkets & Hypermarkets Distribution Channel, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$11.8 Billion by ... Read More
-
Orthopedic Surgical Robots
... at a CAGR of 40.2% over the analysis period 2024-2030. Knee Surgery End-Use, one of the segments analyzed in the report, is expected to record a 37.6% CAGR and reach US$6.6 Billion by the end ... Read More
-
Orthopedic Trauma Devices
... at a CAGR of 4.8% over the analysis period 2024-2030. Internal Fixator, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$11.8 Billion by the end of ... Read More
-
Percutaneous Coronary Intervention (PCI) Devices
... Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2024-2030. Coronary Stents, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$5.4 Billion ... Read More
-
Beta Interferon
... CAGR of 3.0% over the analysis period 2024-2030. The U.S. Market is Estimated at US$968.9 Million While China is Forecast to Grow at 4.5% CAGR The Beta Interferon market in the U.S. is estimated at ... Read More
-
Surgical Procedures
... CAGR of 1.9% over the analysis period 2024-2030. Dental Procedures, one of the segments analyzed in the report, is expected to record a 1.8% CAGR and reach US$31.6 Billion by the end of the analysis ... Read More
-
Artificial Limbs
... CAGR of 4.6% over the analysis period 2024-2030. Upper Extremity Prosthetics, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$925.8 Million by the end of the ... Read More
-
Attapulgite
... 6.9% over the analysis period 2024-2030. Colloidal grade Attapulgite, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$320.0 Million by the end of the analysis period. ... Read More
-
Biochemical Reagents
... CAGR of 8.7% over the analysis period 2024-2030. PCR Reagent Kits, one of the segments analyzed in the report, is expected to record a 11.1% CAGR and reach US$6.3 Billion by the end of the ... Read More
-
Bio-MEMS
... 16.7% over the analysis period 2024-2030. Microfluidic Chips, one of the segments analyzed in the report, is expected to record a 17.1% CAGR and reach US$27.4 Billion by the end of the analysis period. Growth ... Read More
Research Assistance
